AKSO HEALTH GR. (SPADR)/3 Market Cap ($1.60 Billion)
Market Cap & Net Worth: AKSO HEALTH GR. (SPADR)/3 (8HX)
AKSO HEALTH GR. (SPADR)/3 market cap. AKSO HEALTH GR. (SPADR)/3 (F:8HX) has a market capitalization of $1.60 Billion (€1.37 Billion) as of October 31, 2026. Listed on the F stock exchange, this Germany-based company holds position #6679 globally and #989 in its home market, demonstrating a -16.06% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AKSO HEALTH GR. (SPADR)/3's stock price €1.62 by its total outstanding shares 854043910 (854.04 Million).
AKSO HEALTH GR. (SPADR)/3 Market Cap History (2018–2026)
AKSO HEALTH GR. (SPADR)/3 market cap history from 2018 to 2026. Data shows change from $6.17 Billion to $1.11 Billion (-18.78% CAGR). Check AKSO HEALTH GR. (SPADR)/3 stock quote for real-time trading data and today's change.
AKSO HEALTH GR. (SPADR)/3 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AKSO HEALTH GR. (SPADR)/3's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash flow conversion of AKSO HEALTH GR. (SPADR)/3 for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
79.05x
AKSO HEALTH GR. (SPADR)/3's market cap is 79.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $275.58 Million | $6.00 Million | -$16.85 Million | 45.93x | N/A |
| 2023 | $614.06 Million | $13.18 Million | -$1.36 Million | 46.58x | N/A |
| 2024 | $1.03 Billion | $2.41 Million | -$9.46 Million | 425.96x | N/A |
| 2025 | $1.17 Billion | $14.78 Million | -$134.98 Million | 79.05x | N/A |
Competitor Companies of 8HX by Market Capitalization
Companies near AKSO HEALTH GR. (SPADR)/3 in the global market cap rankings as of October 31, 2026. See 8HX net asset quality score to understand what proportion of total assets are financed by equity.
Key companies related to AKSO HEALTH GR. (SPADR)/3 by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #248 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #451 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #626 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.30 Billion USD ( AU$31.51 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #248 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $994.58 |
| #451 | Cencora Inc. | NYSE:COR | $61.32 Billion | $330.84 |
| #626 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $250.48 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.30 Billion | AU$2.73 |
Market Capitalization of AKSO HEALTH GR. (SPADR)/3 (2018–2026)
Market capitalization of AKSO HEALTH GR. (SPADR)/3 from 2018 to today. Between 2018 and today, AKSO HEALTH GR. (SPADR)/3's market cap moved from $6.17 Billion to $ 1.11 Billion, with a yearly change of -18.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.11 Billion | -5.13% |
| 2025 | €1.17 Billion | +13.59% |
| 2024 | €1.03 Billion | +67.48% |
| 2023 | €614.06 Million | +122.83% |
| 2022 | €275.58 Million | -83.76% |
| 2021 | €1.70 Billion | -9.57% |
| 2020 | €1.88 Billion | -26.27% |
| 2019 | €2.55 Billion | -58.74% |
| 2018 | €6.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of AKSO HEALTH GR. (SPADR)/3 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.60 Billion USD |
| MoneyControl | $1.60 Billion USD |
| MarketWatch | $1.60 Billion USD |
| marketcap.company | $1.60 Billion USD |
| Reuters | $1.60 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AKSO HEALTH GR. (SPADR)/3
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more